Generation of inorganic pyrophosphate from extracellular adenosine triphosphate by human serum and plasma

Journal of Rheumatology

Volumn 23, Issue 7, 1996, Pages 1233-1236

  Park, Won ^a,b   Masuda, Ikuko ^c,d   Cardenal Escarcena, Antonio ^d   Palmer, David W ^e   McCarty, Daniel J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Research Fellows in Rheumatology

^c Raymond Kroc Research Associate in Rheumatology

^d Department of Radiology ^*

^e MCW Arthritis Institute

Author keywords

ADENOSINE TRIPHOSPHATE; PLASMA; PYROPHOSPHATE

Indexed keywords

ADENOSINE TRIPHOSPHATE; INORGANIC PYROPHOSPHATASE; LUCIFERASE; MOLYBDIC ACID; PHOSPHATE; PYROPHOSPHATE;

ARTICLE; CATABOLISM; ENZYME ACTIVITY; HALF LIFE TIME; HUMAN; HYDROLYSIS; PLASMA; PRECIPITATION; PRIORITY JOURNAL; SERUM;

ADENOSINE TRIPHOSPHATE; DIPHOSPHATES; EXTRACELLULAR SPACE; FEMALE; HUMANS; HYDROLYSIS; MALE; PHOSPHATES; PHOSPHORUS RADIOISOTOPES; PLASMA; PYROPHOSPHATASES; SUBSTRATE SPECIFICITY;

EID: 0029680099     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kornberg A: On the metabolic significance of phosphorolytic and pyrophosphorolytic reactions. In: Kasha M, Pullman D, eds. Horizons in Biochemistry. New York: Academic Press, 1962.
2. Fleisch H, Russell RGG: Pyrophosphate and polyphosphates. In: H Rasmussen, ed. Pharmacology of the Endocrine System and Related Drugs. New York: Pergamon Press, 1970: 61-100.
3. Ryan LM, McCarty DJ: Calcium Pyrophosphate Crystal Deposition Disease; Pseudogout; Articular Chondrocalcinosis In: McCarty DJ, KoopmanWJ, eds. Arthritis and Allied Conditions, 12th ed. Malvern, PA: Lea & Febiger, 1993:1835-56.
4. McCarty DJ, Kohn NN, Faires JS: The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: The "pseudogout syndrome". I. Clinical aspects. Ann Intern Med 1962;56:711-37.
5. Russell RGG, Waldstrom WB. Lindstedts L: The origin of inorganic pyrophosphate in urine. Clin Sei /969;37:419-29.
6. Silcox DC, Jacobelli SG, McCarty DJ: The identification of inorganic pyrophosphate in human platelets and its release on stimulation with thrombin. J Clin Invest /97J;52:1595-600.
7. Ryan LM, Kozin F, McCarty DJ: Quantification of human plasma inorganic pyrophosphate. I: Normal values in osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 7979;22:886-91.
8. Ryan LM, Kozin F, McCarty DJ: Quantification of human plasma in inorganic pyrophosphate. II: Biological variables. Arthritis Rheum 1979:22:892-5.
9. Ryan LM, Rachow JW, McCarty DJ: Synovial fluid ATP: A potential substrate for the production of inorganic pyrophosphate. JRheumatol /99/;18:716-20.
10. Park W, Masuda I, Cardenal A, Palmer DL, McCarty DJ: Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovia) fluid. J Rheumatol /996;23:665-71.
11. Camerlain M, McCarty DJ, Silcox DC, Jung A: Inorganic pyrophosphate pool size and turnover rate in arthritis joints. J Clin Invest 1975:55:1373-81.
12. Ryan LM, Wortmann RL, Karas B, McCarty DJ: Cartilage nucleoside triphosphate (NTP) pyrophosphohydrolase. I. Identification as an ectoenzyme. Arthritis Rheum 1984; 27:404-9.
13. Gornall AG, Bardawill CJ, David MM: Determination of serum protein by means of the Biuret reaction. / Biol Chem 1949:111:151-66.
14. Rachow JW, Ryan LM: Partial characterization of synovial fluid nucleotide pyrophosphohydrolase. Arthritis Rheum ;985;28:1377-83.
15. Sugino Y, Miyoshi Y: The specific precipitation of orthophosphate and some biochemical applications. J Biol Chem 1964,-239:2360-4.
16. Masuda I, Cardenal A, Haas AL, McCarty DJ: An unique chondrocyte vesicle associated nucleoside triphosphate pyrophosphohydrolase in human synovial fluids (abstr). Arthritis Rheum 1994;(suppl)31: S412.
17. Masuda I, Cardenal A, Ono W, Hamada J, Haas AL, McCarty DJ: Ecto-nucleotide pyrophosphohydrolase in human synovial fluids (abstr). Arthritis Rheum 7995,-(suppl)38:S244.
18. Masuda I, Hamada J, Haas AL, Ryan LM, McCarty DJ: An unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte derived vesicles. J Clin Invest 7995;95:699-705.
19. Gordon JL: Extracellular ATP: Effects, sources and fate. BiochemJ ;9S6,-233:309-19.
20. Jung A, Russell RGG, Bisaz S, Morgan DB, Fleisch H: The fate of intravenously injected 32P-pyrophosphate in dogs. Am J Physiol 1970;218:1757-64.
21. Cardenal A, Masuda I, Haas AL, McCarty DJ: Specificity of an ecto-nucleoside triphosphate pyrophosphohydrolase unique to chondrocyte-derived vesicles (abstr). Arthritis Rheum /994;(suppl)37:S412.
22. Huang R, Rosenbach M, Vaughan R, et al: Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone and cartilage cells. J Clin Invest 1994:94:560-1.
23. Hamada J, Masuda I, Haas AL, McCarty DJ: Evidence for a novel plasma membrane associated nucleoside triphosphate pyrophosphohydrolase in porcine chondrocytes (abstr). Arthritis Rheum ;994;(suppl)37:S412.
24. Ono W, Cardenal A, Masuda I, Hamada J, Haas AL, McCarty DJ: Characterization of a porcine chondrocyte membrane-associated nucleotide pyrophosphohydrolase (abstr). Arthritis Rheum /995;(suppl)38:S244.
25. Cardenal A, Masuda I, Haas AL, Ono W, McCarty DJ: Characterization of nucleotide pyrophosphohydrolase in human serum (abstr). Arthritis Rheum 7995;(suppl)38:S245.
26. Ryan LM, McCarty DJ: Understanding inorganic pyrophosphate metabolism-Toward prevention of calcium pyrophosphate dihydrate crystal deposition (Editorial). Ann Rheum Dis 1995;54:939-41.